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Abstract
Single-cell mass cytometry (SCMC) combines features of traditional flow cytometry (FACS) with mass 
spectrometry, making it possible to measure several parameters at the single-cell level for a complex 
analysis of biological regulatory mechanisms. In this study, we optimized SCMC to analyze hemocytes of 
the Drosophila innate immune system. We used metal-conjugated antibodies (H2, H3, H18, L1, L4, and P1 
at the cell surface, intracellular 3A5 and L2) and anti-IgM (L6 at the cell surface) to detect the levels of 
antigens, while anti-GFP was used to detect crystal cells in the immune induced samples. We investigated 
the antigen expression profile of single cells and hemocyte populations in naive states, in immune induced 
states, in tumorous mutants bearing a driver mutation in the Drosophila homologue of Janus kinase 
(hopTum) and carrying deficiency of a tumor suppressor l(3)mbn1 gene, as well as in stem cell maintenance-
defective hdcΔ84 mutant larvae. Multidimensional analysis enabled the discrimination of the functionally 
different major hemocyte subsets for lamellocytes, plasmatocytes, and crystal cells, and delineated the 
unique immunophenotype of Drosophila mutants. We have identified subpopulations of L2+/P1+ 
(l(3)mbn1), L2+/L4+/P1+ (hopTum) transitional phenotype cells in the tumorous strains and a subpopulation 
of L4+/P1+ cells upon immune induction. Our results demonstrated for the first time that SCMC, combined 
with multidimensional bioinformatic analysis, represents a versatile and powerful tool to deeply analyze 
the regulation of cell-mediated immunity of Drosophila.
KEYWORDS: Mass cytometry; Innate immunity; Drosophila; Single cell analysis, Hemocyte
Introduction
In the animal kingdom, insects have multi-layered innate immune defense mechanisms against invading 
pathogens. Investigation on insects, including the fruit fly Drosophila melanogaster that lacks an acquired 
immune response, plays an important role in our understanding of how innate immunity works [1,2]. The 
conserved signaling pathways between insects and vertebrates, combined with the powerful genetic 
resources of Drosophila, make Drosophila an ideal system to model biological phenomena related to 
human biology and medicine. In Drosophila, microbial infection induces a powerful humoral immune 
response, i.e., release of antimicrobial peptides, the regulation of which is now well understood [3]. 
Parasite infection, wounding, or tumorous development induce a cellular immune response by blood cells, 
i.e., the hemocytes. Recognition, encapsulation, and killing of parasites, or phagocytosis of microorganisms 
[4−6] are exerted by specialized blood cells, the phagocytic plasmatocytes, the encapsulating lamellocytes, 
and the melanizing crystal cells. Quantitative methods are developed to identify mechanisms underlying 
cell-mediated immunity in Drosophila, and these mechanistic studies facilitate further investigations or 
manipulations of immune cells and tissues. In addition, transgenic reporter constructs and monoclonal 
antibodies have also been developed to define functional hemocyte subsets. These systems generally use 
fluorescent molecules in the form of in vivo markers or antibodies, which significantly contribute to our 
understanding of innate immunity [7−9]. 
Recently, single-cell mass cytometry (SCMC) was developed to monitor the expression of marker 
molecules in haematological and other pathological conditions [10,11]. Antibodies against cell type-
specific antigens can be applied to monitor blood cell differentiation during ontogenesis or following 
immune induction. However, traditional antibody staining against only one or two of the cell type-specific 
antigens is not sufficient to describe individual hemocyte populations with complex antigen expression 
patterns. In our previous studies, we adopted and optimized SCMC for Drosophila by multiplex analysis of 
antibodies to transmembrane proteins or intracellular antigens of IgG and IgM types, which are routinely 
used for detecting and discriminating hemocyte subsets of Drosophila melanogaster [7,12−16]. 
The circulating hemocytes of the Drosophila larva are classified into three categories. Two cell types 
are present only in naive condition. These include the small round phagocytic plasmatocytes, which 
account for 95% of the circulating hemocytes, and the melanizing crystal cells, which are similar in size to 
plasmatocytes but contain prophenoloxidase crystals in their cytoplasm. The third cell type is the large 
flattened lamellocyte, which differentiates only in tumorous larvae and in case of immune induction, such 
as wounding or parasitic wasp infestation [17]. Lamellocytes, together with plasmatocytes, are capable of 
forming a multilayer capsule around the wasp egg, thereby killing the invader [18−20]. Plasmatocytes, 
crystal cells, and lamellocytes can be distinguished using cell type-specific monoclonal antibodies or in vivo 
transgenic reporters [7−9,12−15]. All plasmatocytes express P1 antigen (encoded by nimC1) [21], while 
lamellocytes show a characteristic expression of L1 (encoded by atilla), L2, L4, and L6 antigens [14]. 
Following immune induction, a portion of plasmatocytes transdifferentiate into lamellocytes to fight the 
parasitic wasp egg [22−25]. This transdifferentiation process is accompanied by a stepwise alteration of 
lamellocyte-specific antigen expression.
Understanding cancer remains a challenge for scientists. The conserved signal transduction pathways 
in Drosophila and the easy genetic manipulation make fruit fly a frequently used model organism to study 
cancer [26]. Therefore, we investigated two different tumorous Drosophila strains. Onestrain bears a 
driver mutation (hopTum) in the hopscotch (hop) gene encoding a Janus kinase, Hopscotch (Hop), which is 
named as, and the other strain carries a deficiency of the tumor suppressor gene lethal (3) malignant blood 
neoplasm 1 (l(3)mbn), which is named as l(3)mbn1. Constitutive activation of Hop causes melanotic tumors 
and lymph gland hypertrophy in the larvae, as well as malignant neoplasia of blood cells in hopTum [27]. 
The homozygous mutation of l(3)mbn causes malignant transformation, enhanced hemocyte proliferation, 
and lamellocyte differentiation of blood cells in l(3)mbn1 Drosophila [28]. We also investigated the 
immunophenotype of a strain carrying a mutation in hdc (hdcΔ84), which encodes headcase, a Drosophila 
homolog of the human tumor suppressor HECA (Headcase protein homolog), and plays a role in 
hematopoietic stem cell maintenance [29,30]. In addition, Oregon-R (Ore-R) and white mutant w
1118 
were 
included as reference strains, since they were previously considered as wild type and used for the 
generation of mutants [31]. Immune activation was monitored successfully by infestation with the 
Leptopilina boulardi parasitoid wasp of Drosophila larvae in the lozenge>GFP strain (lz-Gal4, UAS-GFP; +; 
+), in which crystal cells were monitored by metal tag labeled anti- GFP antibody [32,33].
We are the first to demonstrate that SCMC is a powerful tool for characterizing hemocytes in different 
Drosophila mutant strains at the protein level. Bioinformatic analysis revealed the characteristic protein 
expression pattern of hemocyte subsets at the single-cell resolution from different genetic variants 
examined. These together suggest that SCMC is a valuable tool for characterizing immune phenotypes in 
any model organisms, in which antibodies against immune components are available.
Results and discussion 
SCMC reveals transitional phenotypes of hemocytes in the tumorous hopTum and l(3)mbn1 strains
We have built the metal tag labeled panel of discriminative antibodies recognizing Drosophila 
melanogaster hemocytes and hemocyte subsets for mass cytometry in this study. We have conjugated 
antibodies against six cell surface antigens (H2, H3, H18, L1, L4, and P1) and two intracellular antigens (3A5 
and L2), as well as one anti-IgM for surface antigen L6. The list of antibodies can be found in Table 1. The 
3A5 and H18 antibodies first reported herein were characterized and validated by indirect 
immunofluorescence and Western blot analyses (Figures S1 and S2). As shown in Figure S1, 3A5 is 
expressed in plasmatocytes and lamellocytes in l(3)mbn1 larvae, but not in lamellocytes of immune-
induced (L.b.) larvae (Figure S1). In contrast, H18 as a pan-hemocyte marker is expressed in all samples 
tested (Figure S2). To optimize antibody efficacies, we compared the fluorescence-activated cell sorting 
(FACS) (Figure S3A) and mass cytometry histograms (Figure S3B) for the antibodies to various antigens. 
Both analyses showed similar reactivity patterns. Single live cells positive for the  pan-hemocyte marker 
H2 were gated for mass cytometry analysis (Figure S4) and all metal tag-labeled antibodies were titrated 
for mass cytometry (Figure S5). 
Next, we compared the expansion of hemocyte populations in the two mutant strains in relation to 
the two wild type strains Ore-R and w1118. The proportion of hemocytes expressing the investigated 
markers is comparable in Ore-R and w1118. However, we detected the emergence of hemocytes expressing 
L1, L2, and L4 markers in l(3)mbn1 and hopTum mutant larvae, reflecting an extensive differentiation of 
lamellocytes, a phenotype characteristic to the blood cell malignancy. A slight elevation in the proportion 
of L6-expressing hemocytes was also detected in hopTum larvae (Figure 1A and Figure S6). The moderate 
change may be explained by the fact that L6 is only expressed by a subset of lamellocytes in tumorous 
larvae [14]. All lamellocyte markers showed a higher expression level in the tumorous hopTum mutant 
compared to the control (Figure 1B and Figure S7). In the hdc∆84 mutant larvae, we detected a moderate 
elevation in the expression level of L2, and a decrease in the expression level of P1 (Figure 1B). However, 
the number of hemocytes expressing lamellocyte markers in the hdc∆84 strain did not increase significantly 
compared to the controls (Figure 1A). This is in line with the finding that in the hdc∆84 mutant larvae, 
lamellocytes differentiate in low numbers, while the number of plasmatocytes is reduced [30]. A reduction 
in the number of plasmatocytess is also evident in the hdc∆84 larvae (Figure 1A).
Multidimensional analysis by the algorithm of t-distributed stochastic neighbor embedding 
(tSNE) and the visualization of stochastic neighbor embedding (viSNE) were carried out within 
the H2 positive live singlets based on H3, H18, L1, L2, L4, L6, P1, and 3A5 marker expression in 
order to map high parametric single-cell data on biaxial plots [34]. The viSNE patterns of hemocyte 
marker expression correlated to the data shown in Figure 1 (Figure 2). The viSNE bioinformatic 
analysis revealed the characteristic protein expression pattern of hemocyte subsets at single-cell 
resolution from the studied genetic variants. We observed a dramatic difference in the viSNE 
patterns between hemocytes isolated from the tumorous l(3)mbn1 and hopTum larvae as compared 
to either control Ore-R or w1118  larvae (Figure 2). Control Ore-R or w1118 hemocytes were not 
discriminated on the viSNE plots showing their minimal genetic distance, but tumorous l(3)mbn1 
and hopTum larvae delineated viSNE maps with the expansion of lamellocytes (Figure 2). In the 
hdc∆84 larvae, we detected a subset of hemocytes that express the 3A5 marker at a high level. This 
subset was detected neither in control, nor in the tumorous larvae, and may represent a cell type 
that differentiates as a precursor for lamellocytes as a consequence of the defect in the maintenance 
of the hematopoietic niche [30]. 
The Uniform Manifold Approximation and Projection (UMAP) analysis was performed by the hemocyte 
subset specific, discriminating markers: L1, L2, L4, L6 for lamellocytes, and P1 for plasmatocytes on the 5 
studied genetic variants of Drosophila melanogaster. The UMAP analysis resulted in the same conclusion 
as tSNE, namely that lamellocyte expansion occurs in tumorous strains l(3)mbn1 and hopTum (Figure S8). 
Both the viSNE and UMAP analysis demonstrate transitional phenotypes of certain lamellocytes and 
plasmatocytes by the co-expression of L2/P1 or L2/L4/P1 in l(3)mbn1 or hopTum, respectively (Figure 2 and 
Figure S8). Merging viSNE graphs outlined characteristic maps of each strain based on high parametric 
mass cytometry data (Figure 3A−C). The Ore-R and w1118 controls showed overlapping patterns on the 
viSNE diagram (Figure 3A−C), with a somewhat lower expression of all markers observed in case of the 
w1118, which may be due to uncontrollable genetic background variations. The dots representing hdc∆84 
hemocytes, mutant of the hdc regulator of hematopoietic stem cell maintenance [30], were detected as a 
zone in between the control and the tumorous patterns (Figure 3C). The most likely explanation to this 
phenomenon is that hdc∆84 homozygous larvae produce lamellocytes, but in a much lower proportion than 
tumorous larvae, the l(3)mbn1 and hopTum [30]. Tumorous hemocytes l(3)mbn1 and hopTum were closely 
mapped and partially overlapping, giving a population clearly separated from the cloud of the controls due 
to the lamellocye-expansive malignant phenotype (Figure 3A−C).
SCMC revealed the transitional phenotypes of hemocytes upon immune induction
In order to monitor the changes in the composition of hemocyte subsets following immune 
induction, we used lz>GFP larvae and complemented the experiment with anti-GFP labeling, 
which enables the detection of crystal cells in that particular strain [32,33]. The tSNE analysis of 
H3, H18, L1, L2, L4, L6, P1, 3A5 markers, and anti-GFP was carried out within the population of 
pan-hemocyte H2  positive live singlets (Figure 4A). We observed a new subset of hemocytes 
appearing 72 h after the infestation of the lz>GFP larvae with the parasitic wasp (Figure 4A and 
Figure S9). This subset of cells accounts for the lamellocytes that differentiate as a result of the 
immune induction since these cells fall into the high expression part of the viSNE for the L1, L2, 
L4, and L6 lamellocyte markers (Figure 4A and Figure S9). This finding is in correlation with an 
increase in the percentage of hemocytes expressing L1 (35.1% vs. 1.81 %), L2 (32% vs. 1.6 %), L4 
(34.36% vs. 1.39 %), and L6 (13.82% vs. 0.935 %) markers (Figure 4B), and the elevated 
expression levels of lamellocyte markers detected in immune-induced larvae compared to the naive 
control (Figure 4C). Interestingly, a new subset of crystal cells (GFP+ cells) appeared in immune-
induced (lz>GFP ii) larvae compared to the control (lz>GFP) (Figure 4A). The viSNE pattern of 
the 3A5 marker also changed significantly after the immune induction, which may be due to the 
newly differentiating hemocytes, similarly to that observed in the hdc∆84 larvae (Figure 4A).
Taken together, we report herein the first panel of metal-conjugated anti-Drosophila antibodies to 
present the applicability of mass cytometry for that canonical model organism of genetics. Recent studies 
identified novel subpopulations of Drosophila hemocytes based on single-cell RNA data [35−38]. These 
findings largely contributed to the definition of hemocyte clusters and to the characterization of 
intermediate cells in the transition from plasmatocyte to lamellocyte. In these experiments, clusters were 
defined by the gene expression patterns of individual hemocytes. The application of “cytometry by time-
of-flight” (CyTOF) can complement these comprehensive transcriptomic studies and verify the existence 
of transitional phenotypes at the protein level. The comparative analysis of Ore-R and white1118 with 
l(3)mbn1, hopTum, and hdcΔ83 revealed transitional phenotypes at the protein level and the differences 
among reference stains: Ore-R and white1118. Both the viSNE and UMAP analysis demonstrated the 
transitional phenotype of certain subpopulations of lamellocytes and plasmatocytes by the co-expression 
of L2/P1 or L2/L4/P1 in l(3)mbn1 or hopTum, respectively. This has been verified by a functional assay of 
immune induction (Figure 4). Our study demonstrates transitional phenotypes (Figure 2, Figure 4A, and 
Figure S8) from single-cell data at the protein level, which places the innate immunity of Drosophila in a 
new biological insight. Additionally, we report herein two novel hemocyte markers, 3A5 with intracellular 
localization and H18 located on the cell surface. The simultaneous detection of several antigens provided 
by CyTOF could not be achieved earlier by traditional microscopy.
The main advantage of CyTOF is the multidimensionality coupled with complex computational tools; 
therefore we propose the extension of the basic panel used in our study with antibodies recognizing 
signaling molecules (e.g., MAP kinases), enzymes (to follow metabolic pathways), and cellular structural 
proteins (e.g., cytoskeletal, cargo proteins) up to 42 markers in one single tube. Another advantage of the 
presented method is that CyTOF enables investigations at the protein level (data of transcriptomics should 
be verified at the protein level) with single-cell resolution. However, we may consider the limitations of 
the CyTOF, which are a.) the availability of antibodies against the protein of interest (which is also a 
limitation for other antibody-based detection approaches). Moreover, anti-tag antibodies are available 
when the protein of interest is labeled with a fusion tag, or the cell of interest is labeled with the expression 
of a marker protein (we report herein the use of anti-GFP). Another limitations are b) the availability of 
the CyTOF technology (it is increasing and most of the research centers are supposed to own the 
technology, as there were 94 instruments already installed in Europe in 2020 January), c) the relatively 
high cost of the CyTOF technology (although the cost should be taken into account by the number of 
investigated markers at the protein level and the number of single cells).
We believe that our method serves as a rapid and cost-effective tool to monitor the alteration of 
hemocyte composition influenced by various agents or mutations. In those cases, it is less expensive and 
easier to perform than single-cell transcriptome analysis. Additionally, the CyTOF can complement 
transcriptomic studies verifying up to 42 simultaneous markers at the protein level with single-cell 
resolution.
Conclusion
The SCMC combines the features of traditional cytometry with mass spectrometry and enables the 
detection of several parameters at single-cell resolution, thus permitting a complex analysis of biological 
regulatory mechanisms. We optimized this platform to analyze the cellular elements, the hemocytes of 
the Drosophila innate immune system. The SCMC analysis with 9 antibodies to all hemocytes and 
hemocyte subsets showed good accordance of fluorescence flow cytometry results in terms of positivity 
on hemocytes of the tumor suppressor mutant l(3)mbn1. Further, we investigated the antigen expression 
profile of single cells and hemocyte populations in Ore-R and w1118 controls, and tumorous (l(3)mbn1, 
hopTum) strains, as well as in a stem cell maintenance defective mutant (hdcΔ84). The immunophenotype of 
immune activation upon infestation with a parasitoid wasp, the differentiation of lamellocytes was 
detected by 10 antibodies in the lz>GFP. 
Multidimensional analysis (viSNE) enabled the discrimination of the major hemocytes: lamellocytes, 
plasmatocytes, and crystal cells and delineated the unique single-cell immunophenotype of the mutant 
strains under investigation. SCMC identified subpopulations of L2+/P1+ (l(3)mbn1), L2+/L4+/P1+ (hopTum) 
transitional phenotype cells in the tumorous strains and a subpopulation of L4+/P1+ cells upon immune 
induction. We demonstrated that mass cytometry, a recent single-cell technology coupled with 
multidimensional bioinformatic analysis at the protein level, represents a powerful tool to deeply analyze 




The following Drosophila lines were used in the current study: w1118 (BSC#9505, Bloomington 
Drosophila Stock Center, USA), Ore-R (wild type), w; hdcΔ84/TM3, Kr>GFP [30], lz-Gal4, UAS-
GFP; +; + (a gift from Bruno Lemaitre, Lausanne, Switzerland) [32], l(3)mbn1/TM6 Tb [28], and 
a homozygous hopTum (BSC#8492) line generated by Dr. Gábor Csordás (BRC, Szeged, Hungary). 
The flies were grown on a standard cornmeal-yeast substrate at 25 °C. 
Production of 3A5 and H18 antibodies
Monoclonal antibodies against Drosophila hemocytes were raised as described previously [14]. Briefly, 
BALB/c mice were immunized by intraperitoneal i.p. injection of 106 hemocytes from late third instar larvae 
of the l(3)mbn1 mutant larvae in Drosophila Ringer’s solution (Sigma-Aldrich, St. Louis, MI). Booster 
injections were given 4, 8, and 13 weeks later. Three days after the last immunization, spleen cells were 
collected and fused with SP2/O myeloma cells by using polyethylene glycol (PEG1450, catalog No. P5402, 
Sigma-Aldrich). Hybridomas were selected in hypoxanthine-aminopterin-thymidine (HAT Supplement, 
21060017 Thermo Fischer Scientific Waltham, MA, USA) medium and maintained as described by Kohler 
and Milstein [14,39]. Hybridoma culture supernatants were screened by indirect immunofluorescence on 
live or acetone fixed permeabilized hemocytes. The selected hybridomas were subcloned three times by 
limiting dilution.
Isolation of hemocytes
Hemocytes were isolated from late third stage larvae by dissecting the larvae in Drosophila Schneider’s 
solution (21720001 Thermo Fisher Scientific, Waltham, MA, USA)) supplemented with 5% fetal bovine 
serum albumin (FBS, F7524-500ML Sigma-Aldrich) plus 0.003% 1-phenyl-2-thiourea (P7629 Sigma-Aldrich).
Immune induction
Lz-Gal4/UAS-GFP flies (lz>GFP) laid eggs for three days in bottles containing standard Drosophila medium. 
After 72 hours, larvae were infected with Leptopilina boulardi wasps for 6 hours. Larvae with visible 
melanotic nodules were selected 72 hours after infestation for isolation of hemocytes. Age and size-
matched larvae were used as control.
Immunofluorescent staining
Immunofluorescent staining was performed as described previously [23]. Briefly, hemocytes were 
attached to multispot slides (SM-011, Hendley-Essex, Loughton, UK) at 21 °C for 45 min. Fixation was 
performed with acetone for 6 min, rehydrated, and subsequently blocked for 20 min in PBS supplemented 
with 0.1% BSA (PBS, phosphate-buffered saline, P4417 Sigma-Aldrich; BSA, bovine serum albumin, A2058 
Sigma-Aldrich), incubated with the indicated antibodies for 1 h at 21 °C, washed three times with PBS and 
incubated with CF-568 conjugated anti-mouse IgG (H+L), F(ab’)2 fragment (1:1000, SAB4600082 Sigma-
Aldrich) for 45 min. Nuclei were labeled with DAPI (D9542 Sigma-Aldrich). The microscopic analysis was 
carried out using a Zeiss Axioskope 2MOT epifluorescent microscope and Axiovision 2.4 software (Zeiss, 
Oberkochen, Germany).
Western blotting
Western blotting was performed in order to test the specificity of the anti-3A5 and anti-H18 antibodies, 
as described previously [12]. Briefly, proteins were differentiated by SDS-PAGE. Following the 
electrophoresis, the proteins were blotted onto a nitrocellulose membrane (Hybond-C, 10564755 
Amersham Pharmacia, Buckinghamshire, UK) in the transfer buffer (25 mM Tris pH 8.3, 192 mM glycine, 
20% (V/V) methanol). The nonspecific binding was blocked with PBS supplemented with 0.1% Tween 20 
(PBST, P1379 Sigma-Aldrich) and 5% non-fat dry milk at 21 °C for 1 h. The blotted proteins were reacted 
to the indicated antibody (anti-3A5 in Figure S1, and anti-H18 in Figure S2) with rotation at 21 °C for 3 h. 
Washing was performed with PBST three times for 10 min and then incubated with HRPO-conjugated anti-
mouse antibody (62-6520 Thermo Fisher Scientific). After three washes with PBST for 10 min, the proteins 
were detected by the ECL-Plus system (32132 Thermo Fisher Scientific) following the manufacturer’s 
recommendations. 
Flow cytometry
Flow cytometry was executed as published previously [12]. Briefly, 20 µl of 107/ml hemocyte suspension 
was plated in insect Schneider’s medium (supplemented with 10% fetal calf serum (Gibco, Thermo Fisher 
Scientific) into each well of a 96-well U-bottom microtiter plate (3635 Corning Life Sciences, Tewksbury, 
MA, USA). Samples for intracellular staining were treated with 2% paraformaldehyde (158127 Sigma-
Aldrich). Hybridoma supernatants (50 µl) were measured to each well and reacted at 4 °C for 45 min. The 
negative control monoclonal antibody was a mouse IgG1 (clone T2/48, anti-human anti-CD45) [40]. After 
the incubation, cells were washed three times with ice-cold Schneider’s medium. The secondary antibody, 
Alexa Fluor 488-labeled anti-mouse IgG (AP124JA4 Sigma-Aldrich) was added (1:1000). After 45 min 
incubation at 4 °C, the cells were washed (three times) with ice-cold Schneider’s medium and acquired on 
FACSCalibur (Beckton Dickinson, Franklin Lakes, NJ, USA).
Mass cytometry
Mass cytometry was performed as we published earlier with some modifications [10,41]. The affinity-
purified monoclonal antibodies were provided by Istvan Ando’s group (BRC, Szeged, Hungary) (Table 1) or 
purchased: anti-IgM, (406527 Biolegend, San Diego, CA, USA [42]), anti-GFP (A11122 Thermo Fisher 
Scientific [43]), and anti-CD45 (3089003B Fluidigm, South San Francisco, CA, USA [44]) and conjugated in 
house according to the instructions of the manufacturer (Maxpar antibody labeling kit, Fluidigm). Optimal 
antibody concentrations were titrated prior to use (Figure S5). The following antibody concentrations were 
used: H2: 5 µg/ml, H3: 5 µg/ml, H18: 5 µg/ml, L1: 1 µg/ml, L2: 7.5 µg/ml, L4: 7.5 µg/ml, L6: 10 µg/ml, anti-
IgM: 10 µg/ml, P1: 7.5 µg/ml, 3A5: 5 µg/ml, and anti-GFP: 10 µg/ml. The negative control monoclonal 
antibody was a mouse IgG1 (clone Hl30, anti-human 89Y labeled CD45) in 1:100 dilution. The isotypes of 
anti-Drosophila antibodies were determined by the IsoStrip™ Antibody Isotyping Kit (11493027001 Roche, 
Basel, Switzerland) according to the instructions of the manufacturer.
Single-cell suspensions were centrifugated at 1100 g at 6 °C for 4 min and incubated with viability 
marker (5 µM cisplatin, 195 Pt, 201064 Fluidigm) on ice in 40 µl PBS for 3 min. Cells were washed twice 
with 200 µl Maxpar Cell Staining Buffer (MCSB, 201068 Fluidigm) and centrifugated at 1100 g at 6°C for 4 
min. Cells were resuspended in 50 µl MCSB, and 50 µl surface antibody cocktail (2 ×) was added, incubated 
on ice for 30 min. Cells were washed with 200 µl MCSB and stained with anti-IgM antibody (volumes were 
the same as in the surface staining), incubated on ice for 30 min. Cells were washed with 200 µl MCSB and 
suspended in 100 µl 1 × Maxpar Fix I buffer (201065 Fluidigm), incubated on ice for 20 min. Cells were 
washed twice with 200 µl Perm-S buffer (201066 Fluidigm) then stained with the intracellular antibody 
cocktail (L2, 3A5, and anti-GFP in Lz>GFP samples), left on ice for 30 min. Cells were washed once with 
MCSB, then fixed with 200 µl 1.6% formaldehyde solution (freshly diluted from 16% Pierce formaldehyde 
in PBS, 28906 Thermo Fisher Scientific), incubated on ice for 10 minutes, then centrifugated at 1300 g at 
6°C for 4 min. After fixation, cells were resuspended in 300 µl Maxpar Fix and Perm buffer (201067 
Fluidigm) containing 125 nM Cell-ID DNA intercalator (191/193 Iridium, 201192A Fluidigm) and incubated 
at 4 °C overnight. Before the acquisition, samples were washed in MCSB twice and in PBS once (without 
Mg2+ and Ca2+, 10010015 Thermo Fisher Scientific) by centrifugation at 1300 g at 6°C for 4 min. Cells were 
counted using the Bürker chamber. For the measurement on Helios, the concentration of cells was set to 
0.5 × 106/ml in cell acquisition solution (CAS, 201240 Fluidigm) supplemented with 10% EQ Calibration 
Beads (201078 Fluidigm). Cells were filtered (30 µm, 04-0042-2316 Celltrics, Sysmex Partec, Görlitz, 
Germany) prior to acquisition. Samples were run on CyTOF Helios (Fluidigm). Bead-based normalization of 
CyTOF data was performed. After randomization, normalization, and FCS file generation, the files were 
further analyzed in Cytobank (Beckman Coulter, Brea, CA, USA). Analysis of the cells was carried out on 
live singlets within the pan-hemocyte marker, H2 positive population. The viSNE (visualization of stochastic 
neighbour embedding) analysis was carried out on 3 × 104 cisplatin negative (live) singlets with the 
following settings: iterations = 1000, perplexity = 30, theta = 0.5).
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Figure legends
Figure 1  Single-cell mass cytometry revealed the expansion of hemocytes in hopTum and l(3)mbn1
A. The percentage of H3, H18, L1, L2, L4, L6, P1, and 3A5 cells were plotted on radar plots for Drosophila 
mutants on Ore-R or w1118 background. B. Comparative heatmap of mass cytometry data (arcsinh-
transformed median intensity values) regarding marker density at single-cell resolution show increased 
expression of H18, L1, L2, and L4 markers in the mutant hopTum and l(3)mbn1 in relation to control, the wild 
type Ore-R. The analysis was performed within the H2 positive live singlets.
Figure 2  Multidimensional comparative analysis by the tSNE algorithm 
The tSNE algorithm dissects the cell relatedness of 5 different Drosophila strains, namely Ore-R, w1118, 
l(3)mbn1, hopTum, and hdcΔ84. The wild type Ore-R and white mutant w1118 (genetic backgrounds) are 
overlapping while both tumorous strains l(3)mbn1 and hopTum represent H18, L1, L2, and L4 expansion. The 
tSNE analysis of H3, H18, L1, L2, L4, L6, P1, and 3A5 markers was carried out within the population of pan-
hemocyte H2 positive live singlets and visualized as viSNE plots. Subpopulations of cells with common 
marker expression patterns are grouped close in the multidimensional space, while cells with different 
marker expression are plotted separately. Coloration is proportional to the intensity of the expression of 
a given marker: the hotter the plot, the higher the level of expression (red plots). Red boxes mark 
transitional phenotypes expressing both lamellocyte (L2 or L4) and plasmatocyte (P1) markers. 
Figure 3  Merging viSNE graphs outline characteristic maps of each strain 
The tSNE analysis was based on H3, H18, L1, L2, L4, L6, P1, and 3A5 marker expression within the pan-
hemocyte H2 positive live singlets (green: Ore-R, blue: w1118, red: l(3)mbn1, lilac: hopTum, and yellow: 
hdcΔ84). A. The viSNE comparison of l(3)mbn1 and its wild-type counterpart, the Ore-R. B. The viSNE 
comparison of w1118, hopTum, and hdcΔ84. C. The viSNE islands of the control cells (Ore-R and w1118) localize 
separately from the tumorous l(3)mbn1 and hopTum hemocytes, while hdcΔ84 represents a transition 
phenotype. 
Figure 4  Immune activation by infestation with the Leptopilina boulardi parasitoid wasp of the 
lozenge>GFP strain
A. viSNE analysis of naive (lz>GFP) and immune induced (lz>GFP i.i.) Drosophila larvae. The tSNE analysis 
of H3, H18, L1, L2, L4, L6, P1, 3A5, and A-GFP was carried out within the population of pan-hemocyte H2 
positive live singlets. Red boxes mark a subpopulation, the transitional phenotype of hemocytes expressing 
both lamellocyte (L4+) and plasmatocyte (P1) markers upon immune induction. B. The percentage of H3, 
H18, L1, L2, L4, L6, P1, anti-GFP (crystal cells), and 3A5 positive cells. C. The heatmap of the (arcsinh-
transformed) median values shows the expression changes of the hemocyte marker expression upon 
immune induction. The analysis was performed within the pan-hemocyte marker H2 positive live singlets. 
A-GFP, anti-GFP marking crystal cells in this particular system.
Supplementary material
Figure S1  Expression pattern and molecular weight of 3A5 
A. The expression of 3A5 in the wild type Ore-R and L. boulardi G486 immune induced Ore-R larvae and 
(B) in the l(3)mbn1 tumor suppressor mutant circulating hemocytes. The 3A5 molecule is expressed in 
plasmatocytes and lamellocytes in l(3)mbn1, but not expressed in lamellocytes of immune (L.b.) induced 
larvae. Fluorescence microscopy and indirect immunofluorescence analysis were carried out with a Zeiss 
Axioskope 2 MOT epifluorescence microscope. Images were taken with a Zeiss Axiocam digital camera. 
Scale bars (black lines): 10 µm. C. Detection of the 3A5 molecule from l(3)mbn1 hemocyte extract. 3A5 is 
detected as a 100 kDa protein in Western blot. 
Figure S2  Expression pattern and molecular weight of H18 
A. The expression of H18 in the wild type Ore-R and L. boulardi G486 immune induced Ore-R larvae and 
(B) in the l(3)mbn1 tumor suppressor mutant circulating hemocytes. H18 molecule is expressed in 
plasmatocytes and lamellocytes both in naive and in immune (L.b.) induced larvae in Ore-R, and in l(3)mbn1 
tumor suppressor mutant circulating hemocytes. Fluorescence microscopy and indirect 
immunofluorescence analysis were carried out with a Zeiss Axioskope 2 MOT epifluorescence microscope. 
Images were taken with a Zeiss Axiocam digital camera. Scale bars (black lines): 10 µm. C. Detection of the 
H18 molecule from l(3)mbn1 hemocyte extract. H18 is detected as a 22.5 kDa protein in Western blot. 
Figure S3  Mass cytometry histograms were verified by fluorescent flow cytometry in Drosophila 
melanogaster hemocytes
Comparison of (A) fluorescence flow cytometry (FACS) data and (B) mass cytometry (CyTOF) data obtained 
from the same l(3)mbn1 hemocytes and same H2, H3, H18, L1, L2, L4, L6, P1, and 3A5 anti-hemocyte 
antibodies (red lines in (A)). The negative control monoclonal antibody used for FACS (black lines in (A)) 
was of mouse origin, the T2/48 IgG1 (anti-human CD45). The negative control monoclonal antibody used 
for CyTOF was of mouse origin, the HI30 clone IgG1 anti-human CD45 labeled by 89Y metal tag.
Figure S4  Gating strategy to define cells, singlets, living cells, and H2+ pan-hemocytes 
Drosophila hemocytes were stained with cisplatin (195 Pt), H2 antibody (147 Sm), DNA intercalators (191Ir 
and 193Ir) as described in the Materials and Methods section. Cells were gated in Cytobank to discriminate 
cells from calibration beads (DNA 191Ir+/140Ce-), to define singlets, to determine living cells (cisplatin 
195Pt-) and H2+ hemocytes in l(3)mbn1strain.
Figure S5  Titration of the metal-tag labeled antibodies for mass cytometry
Antibody titration was performed in order to determine the optimal concentration of (A) anti-H2, anti-H3, 
anti-H18, anti-L1, anti-L2, anti-L4, anti-P1, anti-3A5, and (B) anti-L6, anti-IgM (concentrations are indicated 
in the figure) antibodies in l(3)mbn1strain within the living singlets. The negative control monoclonal 
antibody used for CyTOF was of mouse origin, the HI30 clone IgG1 anti-human CD45 labeled by 89Y metal 
tag. C. The anti-GFP antibody detecting crystal cells was titrated in the (lz>GFP) lozenge strain within the 
H2+ (living singlet) hemocytes.
Figure S6  Representative dot plots of mass cytometry measurements using metal conjugated antibodies 
Antibody labeling was performed in order to detect H3, H18, L1, L2, L4, L6, P1, and 3A5 markers (within 
H2+ living singlets) in the Ore-R, w1118, l(3)mbn1, hopTum, and hdcΔ84 strains as described in Materials and 
Methods section.
Figure S7  Representative histograms of mass cytometry 
Antibody labeling was performed in order to detect H3, H18, L1, L2, L4, L6, P1, and 3A5 markers (within 
H2+ living singlets) in the Ore-R, w1118, l(3)mbn1, hopTum, and hdcΔ84 strains as described in Materials and 
Methods section.
Figure S8  The UMAP analysis showed the lamellocyte expansion in tumorous l(3)mbn1 and hopTum 
strains
The UMAP analysis was performed by the hemocyte subset specific, discriminating markers: L1, L2, L4, L6 
for lamellocytes, and P1 for plasmatocytes on the 5 studied genetic variants of Drosophila melanogaster. 
The metrics were as follows: Euclidean, nearest neighbors: 20; minimum distance: 0.5; 20000 
cells/samples in FlowJo ™  v10.6.1 (Becton Dickinson). Red boxes mark transitional phenotypes of 
hemocytes expressing both lamellocyte (L2 or L4) or plasmatocyte (P1) markers. UMAP, Uniform Manifold 
Approximation and Projection.
Figure S9  Representative histograms of mass cytometry upon immune activation in Drosophila 
melanogaster
Antibody labeling was performed in order to detect H3, H18, L1, L2, L4, L6, P1, crystal cells (A-GFP), and 
3A5 markers in the naive (lz>GFP) and immune induced (lz>GFP i.i.) larvae as described in Materials and 
Methods section. A-GFP, anti-GFP.
Table 1  List of the antibodies used for mass cytometry
Marker Clone Isotype Metal tag Refs.
H2 (Hemese) 1.2 Mouse IgG2a 147 Sm [12,14]
H3 4A12 Mouse IgG1 155 Gd [14]
H18 (Tetraspannin42Ed) H18 Mouse IgG1 164 Dy -
L1 (Atilla) H10 Mouse IgG1 149 Sm [14,15,23]
L2 31A4 Mouse IgG2a 158 Gd [14,23]
L4 (Integrin beta-PS) 1F12 Mouse IgG1 159 Tb [14,23]
L6 (IgM) H3 Mouse IgM – [14,23]
Anti-IgM RMM-1 Rat IgG2a 172 Yb [42]
P1 (NimC1) N47 Mouse IgG1 154 Sm [13,14,21]
3A5 3A5 Mouse IgG2b 169 Tm -
Anti-GFP – Rabbit polyclonal IgG 175 Lu [43]
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